Connect Biopharma

+$0.21 (+1.27%) Today
$0.00 (0.00%) As of 8:00 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CNTB and other ETFs, options, and stocks.

About CNTB

Connect Biopharma Holdings Ltd. engages in the development of therapies for the treatment of T cell-driven inflammatory diseases. Its lead product candidate, CBP-201, is an antibody designed to target interleukin-4 receptor alpha, or IL-4Ra, which is a validated target for the treatment of inflammatory diseases such as atopic dermatitis and asthma.

CEO
Zheng Wei
Employees
—
Headquarters
Taicang, Jiangsu
Founded
2015

CNTB Key Statistics

Market Cap
966.30M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
132.00K
High Today
$17.43
Low Today
$16.27
Open Price
$16.27
Volume
62.51K
52 Week High
$29.27
52 Week Low
$14.02

CNTB Earnings

Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 30, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure